3 Top Biotech News Of The Week (27 August 22)
1. Kymera raises $150 million through the sale of shares to fund development of its clinical and preclinical assets
Kymera which focuses on targeted protein degradation announced that it is raising $150 million to support its ongoing research and development programs and for general corporate purposes.
The biotech has three
